Post-Stroke Medical Complications
CVA · EP 12 · STROKE
Before You Listen
- Prerequisites: stroke severity bands and the National Institutes of Health Stroke Scale (NIHSS) from CVA-01; the acute thrombolysis and thrombectomy framework with the tissue plasminogen activator (tPA) bleed window from CVA-02 and CVA-03; intracerebral hemorrhage (ICH) and antithrombotic management from CVA-04; the Modified Ashworth Scale (MAS) and spasticity ladder from CVA-11.
- Runtime: 1 hour 5 minutes.
- Topic in one line: the medical minefield after stroke. Deep vein thrombosis (DVT) in the paretic limb and the CLOTS trials, the 1-3-6-12 anticoagulation rule, post-stroke depression with the Patient Health Questionnaire-9 (PHQ-9) and the FOCUS-AFFINITY-EFFECTS trials, post-stroke seizures and the no-prophylaxis rule with levetiracetam preferred over phenytoin, pseudobulbar affect (PBA) with dextromethorphan-quinidine, aspiration pneumonia as the leading post-acute cause of death, neurogenic bladder with detrusor hyperreflexia and the noxious-stimulus loop, falls and disuse osteoporosis of the paretic limb, post-stroke fatigue and obstructive sleep apnea (OSA), and the syndrome of inappropriate antidiuretic hormone (SIADH) versus cerebral salt wasting (CSW) sodium showdown.
Vignette. A 71-year-old woman is on inpatient rehabilitation day 9 after a right middle cerebral artery (MCA) ischemic stroke that was treated with intravenous tPA. Her stroke etiology is cardioembolic from chronic atrial fibrillation, and she is restarted on warfarin per the 1-3-6-12 rule. She has dense left hemiplegia, mild dysphagia on a level 2 dysphagia diet, and a PHQ-9 of 14. Overnight she develops a swollen, warm left calf. Morning labs show a serum sodium of 128 mmol/L, serum osmolality 264 mOsm/kg, and urine sodium 62 mmol/L. On exam she is afebrile, with a heart rate of 78, blood pressure 138/82, no orthostatic drop, moist mucous membranes, full neck veins, and a 2 kg weight gain since admission. She has had no further seizures since one self-limited generalized tonic-clonic episode on day 2.
What is the best initial diagnostic study for the swollen calf and why is the D-dimer not the answer, what mechanical prophylaxis from the CLOTS trials should be running and which one is contraindicated, what is the most likely electrolyte diagnosis and what is the treatment, and what antiseizure medication should NOT be added on top of her chronic warfarin?
(Answer at the end of this chapter)
Section 1: DVT in the Paretic Limb, the CLOTS Trials, and the 1-3-6-12 Rule
Bottom line: deep vein thrombosis (DVT) and pulmonary embolism (PE) lead preventable post-stroke deaths; risk peaks in the first 2 weeks and is dramatically higher in the paretic leg because the calf venous pump is offline; compression ultrasonography is the diagnostic study of choice and D-dimer loses its negative predictive value after stroke; intermittent pneumatic compression (IPC) devices work and graduated compression stockings do not (CLOTS); pharmacologic prophylaxis with low-molecular-weight heparin (LMWH) starts within 48 hours of ischemic stroke and 24 hours after tPA; therapeutic anticoagulation for atrial fibrillation follows the 1-3-6-12 rule.
DVT and PE remain leading causes of preventable death in hospitalized stroke patients. Risk peaks during the first 2 weeks after stroke onset, when immobility is greatest and the prothrombotic acute-phase response is most intense. The hemiplegic leg carries substantially higher risk than the non-paretic side because loss of voluntary calf contraction eliminates the venous pump that normally returns blood to the heart. Blood stagnates in the deep veins of the paralyzed leg and activates the coagulation cascade. When a vignette asks which leg is at higher risk after stroke, the answer is always the hemiplegic leg.
The pathophysiology is Virchow’s triad in its purest clinical form. Stasis is created by the failed calf pump. Endothelial injury arises from the systemic inflammatory response to the brain infarct. Hypercoagulability follows the acute-phase elevation in fibrinogen, factor VIII, and von Willebrand factor. All three elements converge in the same paralyzed extremity.
When DVT is suspected, the first diagnostic study is compression ultrasonography, not D-dimer. Compression ultrasound has high sensitivity and specificity for proximal DVT: a normal vein collapses completely under gentle probe pressure, while a vein containing thrombus does not. D-dimer testing has limited utility in the acute stroke population because the baseline is already elevated from the stroke, the inflammatory response, and immobility. The test loses its exclusionary power.
Treatment of confirmed DVT is therapeutic anticoagulation, typically LMWH at full therapeutic doses transitioned to an oral anticoagulant for a duration of 3 months when the provoking factor has resolved. An inferior vena cava (IVC) filter is reserved for venous thromboembolism plus an absolute anticoagulation contraindication, classically a recent large hemorrhagic transformation. The filter does not treat the thrombus; it catches propagating clot before it reaches the pulmonary vasculature. When anticoagulation becomes safe, it is initiated and a retrievable filter removed.
For ischemic stroke, prophylactic LMWH starts within 48 hours of stroke onset. For patients who received intravenous tPA, prophylaxis is delayed 24 hours after the thrombolytic infusion to reduce hemorrhagic transformation. This 24-hour delay is one of the most testable timing details on the boards. For hemorrhagic stroke, prophylaxis is delayed until clinical and radiographic stability, typically 24 to 48 hours after the bleed has stabilized. Unfractionated heparin 5,000 units subcutaneously every 8 to 12 hours is the alternative when LMWH is contraindicated by severe renal insufficiency.
The CLOTS (Clots in Legs Or sTockings after Stroke) trials reshaped mechanical prophylaxis. CLOTS 1 tested thigh-length graduated compression stockings versus no stockings in immobile stroke patients; stockings did not reduce DVT and increased skin complications. CLOTS 2 compared thigh-length to below-knee stockings; conclusion unchanged. CLOTS 3 tested intermittent pneumatic compression (IPC) devices and showed a significant reduction in DVT, both as adjunct to pharmacologic prophylaxis and as primary mechanical prophylaxis when anticoagulation was contraindicated. The board takeaway: graduated compression stockings should not be relied upon, and IPC devices start on day 1.
Timing of therapeutic (full-dose) anticoagulation in cardioembolic stroke from atrial fibrillation follows the 1-3-6-12 rule: 1 day for a transient ischemic attack (TIA), 3 days for a small infarct, 6 days for a moderate infarct, and 12 or more days for a large infarct. Larger infarcts carry higher hemorrhagic-transformation risk, and the dead cortex needs time to scar before anticoagulation. The 1-3-6-12 rule applies to therapeutic dosing for stroke prevention in atrial fibrillation, NOT to the prophylactic LMWH that follows the 48-hour rule for DVT prevention. Confusing the two is the classic vignette trap.
High Yield — DVT and Anticoagulation Timing
- Paretic leg carries dramatically higher DVT risk; risk peak is the first 2 weeks.
- Compression ultrasonography is the diagnostic study of choice; D-dimer is unreliable in stroke (baseline elevated).
- CLOTS 1/2: graduated compression stockings do not reduce DVT and increase skin complications.
- CLOTS 3: intermittent pneumatic compression (IPC) devices significantly reduce DVT; start day 1.
- Prophylactic LMWH within 48 hours of ischemic stroke; delay 24 hours after tPA; 24 to 48 hours after stable hemorrhagic stroke.
- 1-3-6-12 rule for therapeutic anticoagulation in atrial fibrillation: TIA = 1 day, small = 3, moderate = 6, large = 12+ days.
- IVC filter when DVT/PE plus absolute anticoagulation contraindication; remove when anticoagulation is safe.
Board Trap — D-dimer in the post-stroke patient
D-dimer’s clinical value rests on its negative predictive value in low-risk outpatients. A stroke patient is neither low risk nor a clean baseline: the brain infarct itself, the systemic inflammatory response, and immobility all push D-dimer up. A “high” D-dimer in a stroke patient with a swollen calf does not discriminate fresh DVT from background noise. Skip the blood test and go straight to compression ultrasound.
In our post-stroke patients, the D-dimer is already artificially elevated. The acute brain infarction itself triggers fibrin turnover, spiking the D-dimer. An elevated result tells you nothing new. It completely loses its exclusionary power.
— CVA-12 podcast, ~06:04